Nurix Therapeutics Inc. Common stock

NRIXNasdaq · USD · StocksQuote as of 2026-09-18· Exchange session not verified

$25.47

+1.27%

Today

Next earnings call

In 20 days

2026-10-08

Fiscal period

Q3 2026

EPS estimate

— / (-$0.56 est.)

Revenue estimate

— / (— est.)

Timing

unknown

EPS vs. consensus estimate

Actual
Estimate

Q3 24Q1 25Q2 25Q3 25Q 25Q4 25Q1 26Q2 26

Revenue vs. consensus estimate

Actual
Estimate

Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q4 25

EPS surprise history

Q3 25Q2 26

Beat or met consensus in 25% of the last 4 reported quarters.

Previous reports

Values are converted from USD into your selected display currency. Actuals are drawn from SEC filings (XBRL) and Yahoo statements; estimates and surprises from Nasdaq where available.

Fiscal period	Report date	Normalized EPS	EPS surprise	Revenue	Rev. surprise	Actions
Q2 2026	Jul 9, 2026	-$0.81 / (-$0.73 est.)	-10.96%	9,043,000 (unit unavailable) / (— est.)	—	Source
Q1 2026	Apr 8, 2026	-$0.79 / (-$0.76 est.)	-3.95%	6,252,000 (unit unavailable) / (— est.)	—	Source
Q4 2025	Jan 28, 2026	-$0.82 / (— est.)	—	$13.6M / (— est.)	—	Source
Q 2025	Jan 28, 2026	-$0.82 / (-$0.84 est.)	+2.38%	13,577,000 (unit unavailable) / (— est.)	—	Source
Q3 2025	Oct 9, 2025	-$1.03 / (-$0.84 est.)	-22.62%	7,894,000 (unit unavailable) / (— est.)	—	Source
Q2 2025	Jul 9, 2025	-$0.52 / (— est.)	—	$44.1M / (— est.)	—	Source
Q1 2025	Apr 8, 2025	-$0.67 / (— est.)	—	$18.5M / (— est.)	—	Source
Q4 2024	Jan 13, 2025	-0.74 (unit unavailable) / (— est.)	—	$13.3M / (— est.)	—	Source
Q3 2024	Oct 11, 2024	-$0.67 / (— est.)	—	$12.6M / (— est.)	—	Source
Q2 2024	Jul 11, 2024	-$0.71 / (— est.)	—	$12.1M / (— est.)	—	Source
Q1 2024	Apr 10, 2024	-$0.76 / (— est.)	—	$16.6M / (— est.)	—	Source
Q4 2023	Feb 15, 2024	-0.77 (unit unavailable) / (— est.)	—	$15.2M / (— est.)	—	Source
Q3 2023	Oct 12, 2023	-$0.68 / (— est.)	—	$18.5M / (— est.)	—	Source
Q2 2023	Jul 13, 2023	-$0.45 / (— est.)	—	$30.7M / (— est.)	—	Source
Q4 2022	Feb 9, 2023	-0.85 (unit unavailable) / (— est.)	—	$6.8M / (— est.)	—	Source
Q2 2022	Jul 7, 2022	-$1.01 / (— est.)	—	$11.4M / (— est.)	—	Source
Q1 2023	Apr 7, 2022	-$0.95 / (— est.)	—	$9.6M / (— est.)	—	Source
Q4 2021	Jan 27, 2022	— / (— est.)	—	$7.4M / (— est.)	—	Source
Q3 2022	Oct 14, 2021	-$0.65 / (— est.)	—	$10.3M / (— est.)	—	Source
Q2 2021	Jul 13, 2021	-$0.60 / (— est.)	—	$7.1M / (— est.)	—	Source
Q1 2021	Apr 13, 2021	— / (— est.)	—	$5M / (— est.)	—	Source
FY 2020	Feb 16, 2021	— / (— est.)	—	$6.7M / (— est.)	—	Source
Q3 2021	Oct 14, 2020	-$1.09 / (— est.)	—	$4.1M / (— est.)	—	Source